Showing results (251-260 of 366) with videos related to
Sort By:
Pageof 37
Cancer Research|June 17, 2010
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopyNada M S Al-Saffar, L Elizabeth Jackson, Florence I Raynaud, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancyBeatrice M Seddon, Geoffrey S Payne, Laura Simmons, et al.Cancer Chemotherapy and Pharmacology|January 15, 2008
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2010
Inhibition of Hsp90 with resorcylic acid macrolactones: synthesis and binding studiesJames E H Day, Swee Y Sharp, Martin G Rowlands, et al.Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.EMBO Reports|January 12, 2008
A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral buddingHarold B J Jefferies, Frank T Cooke, Parmjit Jat, et al.Cancer Chemotherapy and Pharmacology|September 3, 2018
Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer modelsUdai Banerji, Nivedita Sain, Swee Y Sharp, et al.Nucleic Acids Research|November 30, 2018
canSAR: update to the cancer translational research and drug discovery knowledgebaseElizabeth A Coker, Costas Mitsopoulos, Joesph E Tym, et al.Neoplasia (New York, N.Y.)|April 9, 2008
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenograftsYuen-Li Chung, Helen Troy, Rebecca Kristeleit, et al.Journal of the National Cancer Institute|May 4, 2006
Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapiesPaul Workman, Eric O Aboagye, Yuen-Li Chung, et al.Pageof 37